Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 03 Mar 2026 for Aura Biosciences, Inc..
Filing timeline
BuySaleMark Plavsic
Insider track record
Disclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Mark Plavsic: trading record in brief
Filings by Mark Plavsic span 2 companies, the busiest being Aura Biosciences, Inc. and Fate Therapeutics Inc. The record holds 11 filings, for trades running from 14 June 2021 to 2 March 2026.
Every open-market trade on record is a sale: 6 sales worth €323k. Other entries cover 5 share grants. 2026 to date brings no purchases and 1 sale.
Most recently, on 3 March 2026, the filings show a share grant in Aura Biosciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mark Plavsic
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
62,339 shares0Common StockSEC:0001193125-26-088158:0
15,890 shares@ US$5.0531.3% of flowCommon StockSEC:0001193125-26-055497:0
12,169 shares@ US$6.3544.4% of flowCommon StockSEC:0001193125-25-241622:0
2,151 shares@ US$7.7519.2% of flowCommon StockSEC:0000950170-25-022655:0
90,475 shares0Common StockSEC:0000950170-25-013829:0
7,383 shares@ US$9.8580.8% of flowCommon StockSEC:0000950170-24-115150:0
3,418 shares@ US$5.2415.8% of flowCommon StockSEC:0001209191-23-002976:0
3,719 shares@ US$24.6184.2% of flowCommon StockSEC:0001209191-22-041053:0
33,302 shares0Common StockSEC:0000899243-22-003447:0
59,540 shares0Common StockSEC:0001209191-21-066162:0
38,000 shares0Common StockSEC:0001209191-21-042373:0
11 of 11 declarations
